Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4586_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
05.09.2026
Размер:
18 Мб
Скачать
226
https://t.me/medicina_free
C. O’Connor-Reina and M. Carrasco-Llatas
16.1.3 Clinical Impact Measurement
OMT is considered to be an optional therapy in adults and children with mild to moderate OSA (AHI<15 events/h). It has been shown to be effective in reducing AHI, excessive sleepiness, and in improving quality of life, and adherence to other therapies such as continuous positive airway pressure (CPAP). Patients prescribed OMT should be examined weekly to assure adherence and proper performance of the exercises. There is no consensus on whether these exercises should be performed with a therapist or using other methods such as telemedicine. The impact of OMT by providing feedback to the patient has been evaluated using different methods [2224].
Some authors have recommended the use of the Iowa Oral Performance Instrument (model 2.1; IOPI Medical LLC, Carnation, WA) (IOPI) or the tongue digital spoon (TDS) to measure objectively the muscle tone of the UA [2224]. These instruments can provide objective feedback to patients about whether they are performing exercises properly and increasing the tone of the UA muscles. The IOPI is a portable tool that measures variables related to tongue and lip function by the amount of pressure exerted on a small air-lled bulb. Tongue strength is assessed by measuring the maximum pressure exerted when the patient presses a disposable standard-sized tongue bulb against the roof of the mouth. Lip strength is assessed by measuring the maximum pressure on the bulb located between the cheek and closed teeth, and the patient contracts the buccinator muscle without biting the bulb. The pressure obtained (kPa) is digitally displayed on an LCD panel on the instrument. A series of LED lights representing percentages in 10% increments of a manually set pressure baseline acts in combination with a built-in timer to measure endurance. As an instrument that measures tongue function, the IOPI has been used in several published experiments and has high inter- and intra-rater reliability [25, 26]. Reference values had been obtained from measurements in the population and are provided by the manufacturer [27, 28] (Fig.16.3).
The digital spoon is used as a kitchen tool to estimate the weight (g) of food [24]. To develop the TDS, we used the Soehnle Cooking Star Digital Measuring Spoon, a hand scale with a spoon, with graduations from 0.1g to 500g. This TDS consists of a handle containing the tare and hold buttons. Pressing the hold button allows one to obtain the highest tared value, which is equivalent to the IOPI peak pressure (Fig.16.4). To perform the measurements, the spoon is inverted and a 1cm2 circular
Fig. 16.3 Measurement of the lip strength with the IOPI
16 Orofacial Myofunctional Therapy
https://t.me/medicina_free
227
sticker is placed on the underside to provide a surface measurement (g/cm2). The patient holds the spoon by the handle and, with the elbow resting on a at surface, brings the spoon close to the tongue with an elbow angle of 30°. The device is tared by pressing the hold key to mark 0.0g. The patient then presses the vertex or tip of the tongue as strongly as possible on the marked circumference. When nished, using the index nger of the hand that holds the handle, the patient again presses the hold button. This test is performed fully by the patient to avoid any movements of the spoon that may interfere with the result. Our protocol recommends patients to use this spoon and act on their own control and the IOPI as an additional monthly control to conrm the changes in values as the patient performs the exercises over time. Also, it is a possible alternative method to stimulate patients (Fig.16.5).
Fig. 16.4 Image of the TDS with a dot to show the patient where the tongue should be placed
Fig. 16.5 Use of the TDS measuring the tongue strength
228
https://t.me/medicina_free
C. O’Connor-Reina and M. Carrasco-Llatas
16.1.4 Side Effects, Adherence, andCompliance
Overall, OMT seems to be a safe treatment that has a low incidence of minor compli­cations. Diaféria etal. reported that “there were very few side effects”; however, they did not provide details about them [17]. Randerath etal. performed an RCT of patients using passive OMT with electric stimulation of the tongue. Patients reported higher rates of erythema, skin irritation, and facial pain compared with patients in the pla­cebo group [29]. In a study of patients following a mobile app OMT program, O’Connor etal. reported one case of tongue irritation, one case of temporomandibular joint disorder, and three cases of fatigue that led to rejection of the use of the app [30].
In children, OMT is a safe treatment according to the available evidence. Chuang etal. examined the use of passive OMT with an intraoral mandibular advancement device (MAD). At 1-year follow-up, they found an increase in the vertical facial growth and clockwise rotation of the mandible, which they attributed to the use of the oral device [31].
16.1.5 OMT andTelemedicine
Telemedicine has earned signicance since the publication of the position paper from the American Academy of Sleep Medicine for the diagnosis and treatment of the sleep disordered breathing. Its importance has grown exponentially during COVID-19 pandemic because it is a safe alternative to provide wellness to patient, providers, and staff [32]. Thus, nowadays, it is considered a useful tool, especially mobile technology, in supporting treatments to patients with OSA because of its potential to promote patient empowerment and self-management.
Given the low adherence rates of OMT, in 2017 our research group developed an app to instruct patients with OSA in the use of OMT and to monitor their progress. Initially named Apnea Bye, it later was renamed AirwayGym®. The app is currently available for iOS and Android [10, 33]. It can be thought of as a portable tness app except that its use is intended for OSA patients, rather than athletes, and that thera­pists, rather than trainers, provide the instructions. Its novelty is that it is the rst app in the health-care market that allows the patient to interact directly with the smart­phone without needing any other device. The app focuses on sleep apnea disease and improving proprioceptive decits. When used with the app, the phone provides acoustic feedback on the efcacy of the exercises performed. It includes nine exer­cises based on OMT that aim to improve the tonicity of the muscles involved in the pathogenesis of OSA (Fig.16.6). Before every exercise, an animated demonstration and a video show the patient how to perform the exercise. After each exercise, the patient receives visual, acoustic, and tactile feedback on the success of their perfor­mance as a point score. When the patient nishes the exercises, the results are saved on a networked online storage, and a therapist can evaluate the patient’s perfor­mance of the exercises. Users of the app can follow the progress of their daily activ­ity over time (Fig.16.7). A chat function is available through which the patient can contact the therapist directly.
16 Orofacial Myofunctional Therapy
https://t.me/medicina_free
229
Fig. 16.6 (Video 16.3) An example of one of the exercises that the patient performs using the Airway Gym app ( https://doi.org/10.1007/000-bff)
The main objective of the exercises in the app is to increase the tone of the extrin­sic muscles of the tongue (genioglossus, hyoglossus, styloglossus, and palatoglos­sus). The exercises are based on those described by Guimarães etal. and have been adapted to allow feedback using a smartphone [33]. The rst results obtained with this app have been presented [33]. The app has been reported to be successful in an isolated clinical case [34] and in a preliminary series of 20 patients [30]. In the pre­liminary series, 15 of 20 (75%) patients adhered to the use of the OMT as indicated by their performance of the exercises 5 days a week. In patients who performed the exercises, the AHI decreased signicantly from 25.78±12.6 to 14.1±7.7 events/h. The ESS scores also decreased from 18.2±1.98 to 14.2±7.7 and the minimum O2 saturation decreased from 84.87%±7.02% to 89.27%±3.77%.
230
https://t.me/medicina_free
Fig. 16.7 Interface where patients can follow their own progress, also available for the doctor to conrm the patient compliance
C. O’Connor-Reina and M. Carrasco-Llatas
A pilot RCT was conducted afterwards to evaluate the effects of these exercises in patients with severe OSA after a 3-month follow-up [35]. Forty patients with severe OSA (AHI>30 events/h) were enrolled prospectively and randomized into an intervention group that used the app for 90 sessions or a control group. After the intervention, 28 patients remained adherent to OMT.No signicant changes were observed in the control group. However, the intervention group showed signicant improvements: AHI decreased by 53.4% from 44.7 to 20.88 events/h; the ESS score decreased from 10.33 to 5.37; and minimum O2 saturation decreased by 46.5% from
36.31% to 19.4% (Fig. 16.8). The IOPI maximum tongue score increased from
39.83 to 59.06 kPa, and the IOPI maximum lip score increased from 27.89 to
44.11kPa. The nal AHI correlated signicantly with the improvements in IOPI tongue and lip scores (Fig.16.9). This was the rst RCT performed with OMT in patients with severe OSA, and the results were similar to those obtained with other therapies [36].
16 Orofacial Myofunctional Therapy
https://t.me/medicina_free
Fig. 16.8 Pre- and posttreatment AHI in the patients performing OMT (left side) or in the control group (right side). Only in the OMT there was a signicant reduction in the AHI after therapy
231
Fig. 16.9 Box plot showing the IOPI measurements of the tongue (right) and lips in the OMT and control groups
16.2 Diagnosis ofOrofacial Myofunctional Disorders
andTheir Relationship withSDB
The diagnosis of an orofacial myofunctional disorder is based on an evaluation by a speech therapist. Orofacial myofunctional disorder is dened as one or a combi­nation of the following: (1) abnormal thumb-, nger-, lip-, or tongue-sucking hab­its; (2) inappropriate mouth-open lips-open resting posture (lip incompetence); (3) forward interdental rest posture of the tongue; (4) forward rest position of the tongue against the maxillary incisors; (5) lateral posterior interdental tongue rest
232
https://t.me/medicina_free
Fig. 16.10 (Video 16.4) Pediatric orofacial myofunctional disorder (https://doi.org/10.1007/000-bfd)
C. O’Connor-Reina and M. Carrasco-Llatas
posture; or (6) inappropriate thrusting of the tongue in speaking and/or swallow­ing (tongue thrusting) [37] (Fig.16.10). Guilleminault and others consider that the presence of this disorder during childhood increases the risk of OSA in adult­hood [38, 39].
The main test used to diagnose orofacial myofunctional disorder associated with OSA is the orofacial myofunctional evaluation expanded with scores (OMES), which includes several items and is administered by a speech therapist [40]. This test requires a well-trained speech therapist not available anywhere. Our group is conducting a case control study to evaluate the methods to select patients with OSA for OMT. Our evaluation uses the IOPI and TDS. Our hypothesis is that lower scores obtained with these instruments can complement the information obtained by the OMES questionnaire. We have started this study designed as a protocol to iden­tify suitable patients for OMT [41].
In our practice, we use the results of drug-induced sleep endoscopy (DISE) to explain to the patient the reason for UA collapse and to improve adherence to OMT.Our group has published correlations between IOPI scores and tongue base and classication (T stage) during DISE [22]. Providing patients’ information obtained by PSG, DISE, IOPI, TDS, and OMES gives them feedback on the state of their UA muscles and helps them to understand the disease. In our experience, the rate of adherence to OMT is 65%.
16 Orofacial Myofunctional Therapy
https://t.me/medicina_free
233
16.3 OMT Treatment andEpiglottic Collapse
Kuo et al. consider the epiglottis as a potential collapse site among multilevel obstructions in patients with moderate to severe OSA.They noted that the epiglottic length is highly sensitive for predicting epiglottis attachment to the posterior pha­ryngeal wall and found a cut-off value of 16.6mm. Patients with epiglottic collapse have signicantly lower body mass index (BMI) that does not correspond with the severity of OSA.Patients with epiglottic collapse are expected to respond well to oral devices or positional therapy [42].
Floppy epiglottis causing a trapdoor collapse is one of the most challenging con­ditions for sleep surgeons [43]. Its diagnosis is based on the results of DISE, which allow the surgeon to identify the site of obstruction causing OSA [44]. Until now, the only effective treatment has been surgery to remove the epiglottis totally or par­tially. However, this surgery involves serious risks such as permanent broncho­aspiration, inspiratory dyspnea, or xed swallowing problems. Using OMT, we have conrmed that some patients with epiglottic collapse have improved.
The rst patient reported was a 50-year-old man who came to our ear, nose, and throat (ENT) department, as recommended by his pneumologist, after diagnosed with OSA because he could not tolerate CPAP or MAD.He complained of progres­sive somnolence and headaches. He had had two heart infarctions and bypass sur­gery 3years previously. He was taking anticoagulant medication and had high blood pressure, which was controlled with calcium channel blockers. The ENT examina­tion showed no anatomical ndings to explain his OSA.The patient had Friedman stage 1 and tonsil size grade 1. An examination showed no obstruction and a normal size of the tongue. In a sleep study performed using PSG, his AHI was 31.2 events/h. His BMI was 22.1kg/m2, ESS score was 22, minimal O2 saturation was 91.3%, tongue IOPI score was 34kPa, and lips score was 15kPa. Given this history, we offered him to perform DISE, which revealed a oppy, “trap door” type of epiglottis closure. Three expert sleep surgeons evaluated the video and considered that the only viable option was a partial epiglottectomy or epiglottoplasty under general anesthesia. For personal reasons, the patient declined surgery and did not tolerate the use of MAD. After obtaining his consent for OMT, he started using Airway Gym app for 90 sessions and arranged periodic follow-up. The patient noticed that his headaches and somnolence decreased gradually. His IOPI score improved monthly and reached a tongue score of 51kPa and lips score of 25kPa. DISE was repeated after 3 months and found that the epiglottis collapse had improved (Fig.16.11). A new sleep study found that his AHI had decreased to 17.2 events/h, minimal O2 saturation improved to 95.1%, and ESS score decreased to 15. There was no change in his BMI.The patient is still performing the exercises and a MAD was recommended to improve the residual OSA [33].
The second patient was a 36-year-old man who came to our ENT department with the same problem. The patient exhibited severe OSA with an AHI of 44
234
https://t.me/medicina_free
Fig. 16.11 (Video 16.5) Floppy epiglottis with anteroposterior collapse before and after 90 ses­sions of OMT ( https://doi.org/10.1007/000-bfh)
C. O’Connor-Reina and M. Carrasco-Llatas
events/h, minimum O2 saturation of 81%, Friedman stage 2, tongue IOPI score of 38kPa, and lips score of 21kPa. He did not tolerate CPAP or MAD, and DISE was performed. In this DISE, a lateral type of epiglottis collapse was observed. Surgery was offered to the patient, but he rejected it. Therefore, OMT for 90 sessions was suggested and the patient improved progressively. His IOPI tongue score increased to 48kPa and lips score to 30kPa. His AHI decreased to 29 events/h and his mini­mum O2 saturation improved to 90%. DISE was repeated and it was observed that the collapsibility during an Esmarch maneuver disappeared. Likewise, a recommen­dation was made to the patient to use his MAD again (Fig.16.12). A new sleep study with MAD showed that his AHI was 12 events/h and his minimum O2 satura­tion was 92%. The patient continues to decline surgery (Unpublished data).
These are the two rst cases reported for which the anatomical changes (type of epiglottis collapse) that patients experience after OMT were documented with DISE.The mechanism that explains how these exercises modify the epiglottis col­lapse is unknown. However, in patients who are noncompliant with other treat­ments, OMT could be a helpful therapy with few side effects, as has been demonstrated in these patients [34] Nevertheless, the real-life effect needs to be conrmed in larger series.
In conclusion, OMT is a comprehensive approach that begins by creating aware­ness of the reciprocal impact of OSA on the orofacial musculature and oronasal functions. OMT is a reasonable option for increasing adherence to conventional therapies and, in selected patients, may offer a valid option for treating OSA [45].
16 Orofacial Myofunctional Therapy
https://t.me/medicina_free
Fig. 16.12 (Video 16.6) DISE video showing the epiglottis with lateral collapse before and after OMT ( https://doi.org/10.1007/000-bfj)
235
References
1. Eckert DJ, White DP, Jordan AS, Malhotra A, Wellman A. Dening phenotypic causes of obstructive sleep apnea. Identication of novel therapeutic targets. Am J Respir Crit Care Med. 2013;188(8):996–1004. https://doi.org/10.1164/rccm.201303- 0448OC.
2. White DP.Pathogenesis of obstructive and central sleep apnea. Am J Respir Crit Care Med. 2005;172(11):1363–70. https://doi.org/10.1164/rccm.200412- 1631SO. Epub 2005 Aug 11.
3. Remmers JE, deGroot WJ, Sauerland EK, Anch AM. Pathogenesis of upper airway occlu­sion during sleep. J Appl Physiol Respir Environ Exerc Physiol. 1978;44(6):931–8. https://doi.
org/10.1152/jappl.1978.44.6.931.
4. Remmers JE, Anch AM, deGroot WJ, Baker JP Jr, Sauerland EK.Oropharyngeal muscle tone in obstructive sleep apnea before and after strychnine. Sleep. 1980;3(3–4):447–53. https://doi.
org/10.1093/sleep/3.3- 4.447.
5. Isoni S, Feroah TR, Hajduk EA, Morrison DL, Launois SH, Issa FG, Whitelaw WA, Remmers JE. Anatomy of the pharyngeal airway in sleep apneics: separating anatomic factors from neuromuscular factors. Sleep. 1993;16(8 Suppl):S80–4. https://doi.org/10.1093/sleep/16.
suppl_8.s80.
6. Malhotra A, Fogel RB, Edwards JK, Shea SA, White DP.Local mechanisms drive genioglos­sus activation in obstructive sleep apnea. Am J Respir Crit Care Med. 2000;161(5):1746–9.
https://doi.org/10.1164/ajrccm.161.5.9907109.
7. Sériès F, Côté C, Simoneau JA, Gélinas Y, St Pierre S, Leclerc J, Ferland R, Marc I.Physiologic, metabolic, and muscle ber type characteristics of musculus uvulae in sleep apnea hypopnea syndrome and in snorers. J Clin Invest. 1995;95(1):20–5. https://doi.org/10.1172/JCI117640.
8. Guilleminault C, Huang YS, Quo S. Apraxia in children and adults with obstructive sleep apnea syndrome. Sleep. 2019;42(12):zsz168. https://doi.org/10.1093/sleep/zsz168.
9. Garliner D.Myofunctional therapy. Gen Dent. 1976;24(1):30–40.